Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. News
    3. Search results
    Displaying results 251 - 275 of 309 Clear search
    Wellcome Sanger Institute
    18 Sep 2014

    Gene variant dramatically reduces ‘bad’ lipids

    Research using data collected from around 4,000 healthy people in the UK has enabled scientists to identify a rare genetic variant that dramatically reduces levels of certain types of lipids in the blood. The study is the first to emerge from the UK10K Project’s cohort of samples from the general public and demonstrates the power of whole genome sequencing at scale.

    Wellcome Sanger Institute
    08 Aug 2014

    Genome-wide association study in disease-causing bacteria paves way for clinical tool

    Researchers have developed a powerful new tool to identify genetic changes in disease-causing bacteria that are responsible for antibiotic resistance. The results from this technique could be used in clinics within the next decade to decide on the most effective treatments for diseases such as pneumonia and meningitis.

    Wellcome Sanger Institute
    31 Jul 2014

    New malaria vaccine candidates identified

    Researchers have discovered new vaccine targets that could help in the battle against malaria. Taking a new, large-scale approach to this search, researchers tested a library of proteins from the Plasmodium falciparum parasite with antibodies produced by the immune systems of a group of infected children.

    Wellcome Sanger Institute
    12 May 2014

    Atlas shows how genes affect our metabolism

    In the most comprehensive exploration of the association between genetic variation and human metabolism, researchers have provided unprecedented insights into how genetic variants influence complex disease and drug response through metabolic pathways.

    Wellcome Sanger Institute
    25 Apr 2014

    Tsetse fly genome reveals weaknesses

    Mining the genome of the disease-transmitting tsetse fly, researchers have revealed the genetic adaptions that allow it to have such unique biology and transmit disease to both humans and animals.

    Wellcome Sanger Institute
    24 Apr 2014

    Impact of whooping cough vaccination revealed

    The most comprehensive study to date of the family of bacteria that causes whooping cough points to more effective vaccine strategies and reveals surprising findings about the bacteria’s origin and evolution. The new results could alter public health strategies to control this respiratory disease, which kills 195,000 children worldwide each year.

    Wellcome Sanger Institute
    17 Apr 2014

    Sperm meets egg: protein essential for fertilisation discovered

    Researchers at the Wellcome Trust Sanger Institute have discovered interacting proteins on the surface of the sperm and the egg essential to begin mammalian life. These proteins, which allow the sperm and egg to recognise one another, offer new paths towards improved fertility treatments and the development of new contraceptives.

    Wellcome Sanger Institute
    15 Apr 2014

    Virus-fighting genes linked to mutations in cancer

    Cambridge researchers have found a major piece of genetic evidence that confirms the role of a group of virus-fighting genes in cancer development.

    Wellcome Sanger Institute
    02 Apr 2014

    The Sanger Institute honoured with Athena SWAN Bronze Award

    The Wellcome Trust Sanger Institute is one of the first six research institutes in the UK to be recognised by the Equality Challenge Unit's Athena SWAN Charter, a scheme that recognises excellence in women's employment in science, technology, engineering, maths and medicine.

    Wellcome Sanger Institute
    31 Mar 2014

    Genetic mutations warn of skin cancer risk

    Researchers have discovered that mutations in a specific gene are responsible for a hereditary form of melanoma.

    Wellcome Sanger Institute
    21 Feb 2014

    Out of Africa: the evolution of Plasmodium vivax

    Researchers have shown that Plasmodium vivax, which causes the majority of human malaria infections in Asia and Latin America, actually originated in Africa.

    Wellcome Sanger Institute
    13 Jan 2014

    Immune system development linked to leukaemia

    Scientists have discovered a genetic signature that implicates a key mechanism in the immune system as a driving force for a type of childhood leukaemia.

    Wellcome Sanger Institute
    10 Jan 2014

    Why is type 2 diabetes an increasing problem?

    Contrary to a common belief, researchers have shown that genetic regions associated with increased risk of type 2 diabetes were unlikely to have been beneficial to people at stages through human evolution.

    Wellcome Sanger Institute
    09 Dec 2013

    Gene promotes one in a hundred tumours

    Researchers have identified a gene that drives the development of tumours in over one per cent of all cancer patients. This is the first time that the gene CUX1 has been broadly linked to cancer development.

    Wellcome Sanger Institute
    04 Dec 2013

    What makes the deadliest form of malaria specific to people?

    Researchers have discovered why the parasite that causes the deadliest form of malaria only infects humans.

    Wellcome Sanger Institute
    21 Nov 2013

    Fred Sanger, 1918-2013

    Fred Sanger, who died on Tuesday (19 November 2013), aged 95, was the quiet giant of genomics, the father of an area of science that we will explore for decades to come. His achievements rank alongside those of Francis Crick, James Watson and Rosalind Franklin in discovering the structure of DNA.

    Wellcome Sanger Institute
    24 Oct 2013

    Cutting edge new build for Genome Campus

    The Wellcome Trust Conference Centre has received planning permission to build an innovative development that will cater for a wide range of audiences such as conference delegates, school students and staff of the Wellcome Trust Genome Campus. The £9.7 million project, known as the Kitchen Garden Enclosure, is reminiscent of the famous glass ceiling in the British Museum and will include a new…

    Wellcome Sanger Institute
    20 Sep 2013

    £25m to kick-start 'industrial revolution' in regenerative medicine

    The Wellcome Trust Sanger Institute is participating in a £25 million programme to develop regenerative medicine therapies for a range of applications, including Parkinson's disease, cardiovascular disease, wound and musculoskeletal repair, eye disorders and deafness.

    Wellcome Sanger Institute
    29 Aug 2013

    Parasitic worm genome uncovers potential drug targets

    Researchers have identified five enzymes that are essential to the survival of a parasitic worm that infects livestock worldwide and is a great threat to global food security. Two of these proteins are already being studied as potential drug targets against other pathogens.

    Wellcome Sanger Institute
    20 Aug 2013

    Hand-in-hand with the local community

    Wellcome Trust Conference Centre wins prize for engaging with local communities around Cambridge

    Wellcome Sanger Institute
    15 Aug 2013

    Cancer’s origins revealed

    Cambridge researchers have provided the first comprehensive compendium of mutational processes that drive tumour development. Together, these mutational processes explain most mutations found in 30 of the most common cancer types. This new understanding of cancer development could help to treat and prevent a wide range of cancers.

    Wellcome Sanger Institute
    05 Aug 2013

    Distinct brain disorders biologically linked

    Disruption to the gene TOP3B increases susceptibility to schizophrenia and a learning disorder

    Wellcome Sanger Institute
    09 Jul 2013

    New opportunities to treat bowel cancer

    Researchers have discovered the genetic processes that cause specific types of bowel cancer. Using this knowledge, they identified cancer drugs that target these genes. Their findings offer the opportunity to develop personalised treatment based on a person’s genetic profile.

    Wellcome Sanger Institute
    02 Jul 2013

    Sanger Institute researchers spark discussion on genomes and healthcare

    The Sanger Institute is sending 50 of its researchers to this year’s Royal Society Summer Science Exhibition to take visitors on a journey through genetic discoveries and find out what they think should be done with their DNA data.

    Wellcome Sanger Institute
    25 Jun 2013

    Getting to grips with migraine

    Researchers at the Wellcome Trust Sanger Institute have identified some of the biological roots of migraine from a large-scale genome study.

    Pagination

    • First page «
    • Previous page ‹
    • …
    • Page 9
    • Page 10
    • Current page 11
    • Page 12
    • Page 13
    • Next page ›
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS